Treatment with LL-37 peptide enhances antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancer
about
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapyThe Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer DrugsToll-like Receptors in Ovarian Cancer as Targets for ImmunotherapiesThe host defense peptide cathelicidin is required for NK cell-mediated suppression of tumor growthAntimicrobial peptide LL-37 promotes the viability and invasion of skin squamous cell carcinoma by upregulating YB-1.Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications.A TLR9 agonist enhances the anti-tumor immunity of peptide and lipopeptide vaccines via different mechanismsIntraperitoneal administration of poly(I:C) with polyethylenimine leads to significant antitumor immunity against murine ovarian tumors.Enhanced antitumor effects by docetaxel/LL37-loaded thermosensitive hydrogel nanoparticles in peritoneal carcinomatosis of colorectal cancer.The Role of Cathelicidin LL-37 in Cancer Development.Antimicrobial peptide LL-37 promotes the proliferation and invasion of skin squamous cell carcinoma by upregulating DNA-binding protein A.Carbamylated LL-37 as a modulator of the immune response.Antimicrobial peptide LL-37 promotes YB-1 expression, and the viability, migration and invasion of malignant melanoma cells.Oligonucleotide delivery in cancer therapy.Adjuvants for enhancing the immunogenicity of whole tumor cell vaccines.Toll-like receptors in human papillomavirus infection.Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides.Mitochondrial targeted peptides for cancer therapy.Unique features of human cathelicidin LL-37.Antifungal plant defensins: increased insight in their mode of action as a basis for their use to combat fungal infections.Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications.Plasmacytoid dendritic cells and their therapeutic activity in cancerSpotlight on Human LL-37, an Immunomodulatory Peptide with Promising Cell-Penetrating Properties.Synergy effects of Polyinosinic-polycytidylic acid, CpG oligodeoxynucleotide, and cationic peptides to adjuvant HPV E7 epitope vaccine through preventive and therapeutic immunization in a TC-1 grafted mouse model.A Novel Biological Role for Peptidyl-Arginine Deiminases: Citrullination of Cathelicidin LL-37 Controls the Immunostimulatory Potential of Cell-Free DNA.Ceragenin CSA-13 as free molecules and attached to magnetic nanoparticle surfaces induce caspase-dependent apoptosis in human breast cancer cells via disruption of cell oxidative balance.Developments of Cyanobacteria for Nano-Marine Drugs: Relevance of Nanoformulations in Cancer Therapies.Optimized Microwave Assisted Synthesis of LL37, a Cathelicidin Human Antimicrobial Peptide
P2860
Q26745710-88C20919-E5B6-475C-85B9-60A7808DC64AQ26801532-C00913FF-7592-46EB-BF40-FF3BCD699FE7Q26861234-AF20A9EA-AA78-4855-A19C-576176178AC6Q30933550-19269109-D109-4D5B-B7CA-F136B7DBB0BEQ33846843-8DBE7D53-E881-47FE-9F0C-1F704D147034Q34091593-E1BBE3AD-D321-41EA-A524-386874D1679CQ35895400-1710A5FC-F7D3-42B1-87C6-5B91426E76F2Q36244190-5237B677-8B7A-430A-9F44-FA0AAB0229E5Q36354776-ADE4CDD8-6C11-494B-9D5D-A189EDDEFF78Q36465085-1068D8C8-CC11-455F-813E-6F0F6F090B7EQ37204334-86A1D736-A135-4922-9ECA-76D47669AF47Q37483146-BC178030-9E9E-44B2-9A49-ABC542993F2CQ37707536-050B81B5-F276-464C-913E-4E869CB174BBQ37803214-EE4AFE93-07E5-4893-BC83-1F1A46A2B858Q37873932-E4337CFB-1A32-4CC5-B5AF-9685B5EC229AQ38084160-776CD887-2B65-4557-A24D-F4B55D543D7AQ38160482-4307D017-4F88-47D2-998F-7B31BC36CA70Q38542765-9F7649B4-325B-4A81-99AB-4F34A0890D3CQ38598753-CFE2CE02-5D3B-4AA5-B80C-28B86FB14B4BQ38740360-4495D99D-585F-47C8-B66A-84F3E4FB9B13Q39250554-157C24F5-63A3-4DE8-8A37-07843ACEAEE2Q42321646-B3AFF8C2-AEAA-4A90-BF62-33CAF03B4137Q46697816-8A0A5395-3B71-4C08-9051-8F7DDE98B301Q47224779-C689E799-20CB-4714-BAA6-F030C31FBCE0Q52687725-5CD37ABA-80EA-4554-BF50-93FFF2FAD429Q55255494-4C75942A-B674-45C1-AB84-2173F2CE9520Q55453641-55CCC95A-7D26-4B83-9B72-781101957C9CQ57179930-D724F353-F9BD-4F07-8B5B-32EAB2685B0E
P2860
Treatment with LL-37 peptide enhances antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancer
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Treatment with LL-37 peptide e ...... eotides against ovarian cancer
@ast
Treatment with LL-37 peptide e ...... eotides against ovarian cancer
@en
type
label
Treatment with LL-37 peptide e ...... eotides against ovarian cancer
@ast
Treatment with LL-37 peptide e ...... eotides against ovarian cancer
@en
prefLabel
Treatment with LL-37 peptide e ...... eotides against ovarian cancer
@ast
Treatment with LL-37 peptide e ...... eotides against ovarian cancer
@en
P2093
P2860
P356
P1433
P1476
Treatment with LL-37 peptide e ...... eotides against ovarian cancer
@en
P2093
Archana Monie
Chi-Mu Chuang
Chien-Fu Hung
Chih-Ping Mao
P2860
P304
P356
10.1089/HUM.2008.124
P577
2009-04-01T00:00:00Z